Dennis, Brittany B.
Sanger, Nitika
Bawor, Monica
Naji, Leen
Plater, Carolyn
Worster, Andrew
Woo, Julia
Bhalerao, Anuja
Baptist-Mohseni, Natasha
Hillmer, Alannah
Rice, Danielle
Corace, Kim
Hutton, Brian
Tugwell, Peter
Thabane, Lehana
Samaan, Zainab http://orcid.org/0000-0002-5974-9361
Funding for this research was provided by:
CIHR Drug Safety and Effectiveness Network (DSEN) grant (grant number: 126639)
Canadian Institutes for Health Research Sponsorship Grant (CIHR (sponsor award number 156306))
Article History
Received: 9 February 2019
Accepted: 13 December 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: Participants were recruited as part of the Genetics of Opioid Addiciton (GENOA) research collaborative between McMaster University and the Population Genomics Program. GENOA is a prospective cohort investigation approved by the Hamilton Integrated Research Ethics Board. Amendments to the GENOA study protocol to include new questions as part of our interview tool to allow for qualitative interviews exploring patient important outcomes was approved (HIREB #0168).
: This study does not include any individual person’s data requiring consent for publication.
: The authors declare that they have no competing interests.